Biju; Purakkattle J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Biju; Purakkattle J..The latest application filed is for "c21 thioethers as glucocorticoid receptor agonists".

Company Profile

0.12.16

Biju; Purakkattle J. - Piscataway NJ US
Biju; Purakkattle J. - Scotch Plains NJ
Biju; Purakkattle J. - Piscaraway NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
C20-C21 substituted glucocorticoid receptor agonists Grant 8,524,697 - Anthes , et al. September 3, 2	2013-09-03
C21 Thioethers As Glucocorticoid Receptor Agonists App 20110262368 - Anthes; John C. ; et al.	2011-10-27
3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands App 20110213029 - Taveras; Arthur G. ; et al.	2011-09-01
C20-c21 Substituted Glucocorticoid Receptor Agonists App 20110182828 - Anthes; John C. ; et al.	2011-07-28
3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands Grant 7,964,646 - Taveras , et al. June 21, 2	2011-06-21
Treatment of chemokine mediated diseases Grant 7,960,433 - Taveras , et al. June 14, 2	2011-06-14
3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands Grant 7,947,720 - Taveras , et al. May 24, 2	2011-05-24
5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as CXC-chemokine receptor ligands Grant 7,897,606 - Biju March 1, 2	2011-03-01
Thiadiazoles as CXC- and CC- chemokine receptor ligands Grant 7,786,149 - Biju , et al. August 31, 2	2010-08-31
Di-substituted oxadiazoles as CXC-chemokine receptor ligands Grant 7,718,678 - Biju May 18, 2	2010-05-18
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands Grant 7,691,856 - Taveras , et al. April 6, 2	2010-04-06
Isothiazole dioxides as CXC- and CC-chemokine receptor ligands Grant 7,671,212 - Taveras , et al. March 2, 2	2010-03-02
3,4-di-substituted Cyclobutene-1,2-diones As Cxc-chemokine Receptor Ligands App 20090306079 - Taveras; Arthur G. ; et al.	2009-12-10
Thiadiazoles As Cxc- And Cc- Chemokine Receptor Ligands App 20080090823 - Biju; Purakkattle J. ; et al.	2008-04-17
Thiadiazoles AS CXC- and CC- chemokine receptor ligands Grant 7,338,968 - Biju , et al. March 4, 2	2008-03-04
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands App 20070264230 - Taveras; Arthur G. ; et al.	2007-11-15
Treatment of chemokine mediated diseases App 20070155756 - Taveras; Arthur G. ; et al.	2007-07-05
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands App 20070021494 - Taveras; Arthur G. ; et al.	2007-01-25
5,6-Di-substituted oxadiazolopyrazines and thiadiazolopyrazines as CXC-chemokine receptor ligands App 20070015731 - Biju; Purakkattle J.	2007-01-18
Di-substituted oxadiazoles as CXC-chemokine receptor ligands App 20070004682 - Biju; Purakkattle J.	2007-01-04
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands Grant 7,132,445 - Taveras , et al. November 7, 2	2006-11-07
Thiadiazoles AS CXC- and CC- chemokine receptor ligands App 20060223864 - Biju; Purakkattle J. ; et al.	2006-10-05
Isothiazole dioxides as CXC- and CC-chemokine receptor ligands App 20060025453 - Taveras; Arthur G. ; et al.	2006-02-02
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine receptor ligands App 20040186142 - Taveras, Arthur G. ; et al.	2004-09-23
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands App 20040147559 - Taveras, Arthur G. ; et al.	2004-07-29
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands App 20040106794 - Taveras, Arthur G. ; et al.	2004-06-03
Treatment of chemokine mediated diseases App 20040053953 - Taveras, Arthur G. ; et al.	2004-03-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.